The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID

NCT ID: NCT02971488

Last Updated: 2019-09-13

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 529 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2017-01-15
• Study Completion Date: 2019-05-10

Brief Summary

Screening, diagnosis and treatment of HCV in PWID, should be part of a harm reduction strategy. Treatment of HCV infected PWID should be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population. More frequent diagnosis, new methods that prevent loss of tracking, and access to antiviral treatment are all strategies that must be implemented jointly if the prevalence of HCV infection in our setting is to be reduced.

Conditions

Hepatitis C; Drug Users; Harm Reduction; HIV

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Persons who inject drugs (PWID)

The study population comprises persons who visit the Cañada Real Galiana shantytown on the outskirts of Madrid, where 90% of illegal drugs in the region are sold and consumed.

Screening for HCV in PWID and Linkage-To-Care

Intervention Type: OTHER

Screening, diagnosis and treatment of HCV in PWID, will be part of a harm reduction strategy.

Treatment of HCV infected PWID will be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population.

Interventions

Screening for HCV in PWID and Linkage-To-Care

Screening, diagnosis and treatment of HCV in PWID, will be part of a harm reduction strategy.

Treatment of HCV infected PWID will be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• PWID
• >18 years of age
• Signed consent form

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Instituto de Salud Carlos III

OTHER_GOV

Sponsor Role: collaborator

Fundacion SEIMC-GESIDA

OTHER

Sponsor Role: collaborator

Hospital Universitario Infanta Leonor

OTHER

Sponsor Role: lead

Responsible Party

Pablo Ryan

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Provided Documents

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

HUIL 15/03

Identifier Type: -

Identifier Source: org_study_id